An experimental antibody treatment reduced viral load in some COVID-19 patients. That may also be a positive sign for vaccines
October 01, 2020 at 15:03 PM EDT
Promising new clinical data for an experimental COVID-19 treatment hints at a secondary but possibly more important takeaway for investors: if this neutralizing antibody treatment works, so will the coronavirus vaccines that are in development.
